Search
for
Sort by
Research 91–120 of 1000+
- Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor
- Cetuximab-Associated Elongation of the Eyelashes
- Cutaneous Drug Eruptions Associated with the Use of New Oncological Drugs
- Tideglusib promotes wound healing in aged skin by activating PI3K/Akt pathway
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Suppression of Wnt/β-catenin signaling by EGF receptor is required for hair follicle development
- Allopregnanolone promotes proliferation and differential gene expression in human glioblastoma cells
- A Case of Cicatricial Alopecia Associated with Erlotinib
- Genetically modified laboratory mice with sebaceous glands abnormalities
- Ligand‐independent epidermal growth factor receptor hyperactivation increases sebaceous gland size and sebum secretion in mice
- Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities
- Trichoscopic Findings of Erosive Pustular Dermatosis of the Scalp Associated with Gefitinib
- Cutaneous Lesions in the Rat Following Administration of an Irreversible Inhibitor of erbB Receptors, Including the Epidermal Growth Factor Receptor
- Role for the Epidermal Growth Factor Receptor in Chemotherapy-Induced Alopecia
- Treatment of Epidermal Growth Factor Receptor Inhibitor-Induced Acneiform Eruption with Topical Recombinant Human Epidermal Growth Factor
- Novel acquisitions on the immunoprotective roles of the EGF receptor in the skin
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Skin toxicity of anti‐cancer therapy
- The incidence and management of cutaneous adverse events of the epidermal growth factor receptor inhibitors
- Perifollicular Xanthomas Associated with Epidermal Growth Factor Receptor Inhibitor Therapy
- Dermatologic Reactions to Targeted Therapy
- Erlotinib-Induced Skin Inflammation Is IL-1 Mediated in KC-Tie2 Mice and Human Skin Organ Culture
- Nrf2-Mediated Expansion of Pilosebaceous Cells Accelerates Cutaneous Wound Healing
- Brief Report: Requirement of TACE/ADAM17 for Hair Follicle Bulge Niche Establishment
- Regulation of Semaphorin3A in the process of cutaneous wound healing
- Cetuximab-induced hypertrichosis of the scalp and eyelashes
- Management of Dermatologic Toxicities
- Trichomegaly of the Eyelashes After Treatment with Erlotinib in Non-small Cell Lung Cancer
- A conditional multi-trait sequence GWAS discovers pleiotropic candidate genes and variants for sheep wool, skin wrinkle and breech cover traits
- The epidermal growth factor receptor decreases Stathmin 1 and triggers catagen entry in the mouse